Biblio

Filters: Author is Labopin, Myriam [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Nagler, A., Rocha, V., Labopin, M., Unal, A., Ben Othman, T., Campos, A., Volin, L., Poire, X., Aljurf, M., Masszi, T., et al. (2013). Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen--A Report From the Acute Leukemia Worki.J Clin Oncol.

Christopeit, M., Labopin, M., Gorin, N.-C., Saraceni, F., Passweg, J., Forcade, E., Maertens, J., van Lint, M.Teresa, Bosi, A., Niederwieser, D., et al. (2018). Allogeneic Stem Cell Transplantation following Relapse post Autologous Stem Cell Transplantation in adult patients with Acute Myeloid Leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.Am J Hematol.

Bazarbachi, A.Hamid, Hamed, R.Al, Labopin, M., Afanasyev, B., Hamladji, R.-M., Beelen, D., Eder, M., Scheid, C., Wu, D., Bunjes, D., et al. (2019). Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party.Bone Marrow Transplant.

Hawkey, C.J., Allez, M., Clark, M.M., Labopin, M., Lindsay, J.O., Ricart, E., Rogler, G., Rovira, M., Satsangi, J., Danese, S., et al. (2015). Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.Jama314, 2524-2534.

C

Shem-Tov, N., Labopin, M., Moukhtari, L., Ciceri, F., Esteve, J., Giebel, S., Gorin, N.-C., Schmid, C., Shimoni, A., Nagler, A., et al. (2014). Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Oncologist.

Shimoni, A., Labopin, M., Savani, B., Byrne, M., Volin, L., Finke, J., Niederwieser, D., Ehninger, G., Blaise, D., Beelen, D., et al. (2019). Comparable Long-Term Outcome after Allogeneic Stem-Cell Transplantation from Sibling and Matched Unrelated Donors in AML Patients Older than 50 years. A Report on Behalf of the ALWP of EBMT.Biol Blood Marrow Transplant.

Lee, C.J., Labopin, M., Beelen, D., Finke, J., Blaise, D., Ganser, A., Itälä-Remes, M., Chevallier, P., Labussière-Wallet, H., Maertens, J., et al. (2018). Comparative Outcomes of Myeloablative and Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Acute Myeloid Leukemia with Prior Solid Tumor: a report from the ALWP of the EBMT.Am J Hematol.

E

Tichelli, A., Beohou, E., Labopin, M., Socié, G., Rovó, A., Badoglio, M., van Biezen, A., Bader, P., Duarte, R.F., Basak, G., et al. (2018). Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.Jama Oncol.

H

Bazarbachi, A., Labopin, M., Angelucci, E., Gulbas, Z., Ozdoğu, H., Arat, M., de Rosa, L., Pastano, R., Pioltelli, P., Montserrat, R., et al. (2020). Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party.Biol Blood Marrow Transplant.

Le Bourgeois, A., Labopin, M., Guillaume, T., Delaunay, J., Foucher, Y., Tessoulin, B., Malard, F., Ayari, S., Peterlin, P., Derenne, S., et al. (2014). HHV-6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.Exp Hematol.

Czerw, T., Labopin, M., Schmid, C., Cornelissen, J.J., Chevallier, P., Blaise, D., Kuball, J., Vigouroux, S., Garban, F., Lioure, B., et al. (2016). High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelate.Oncotarget.

K

Shimoni, A., Labopin, M., Lorentino, F., van Lint, M.Teresa, Koc, Y., Gulbas, Z., Tischer, J., Bruno, B., Blaise, D., Pioltelli, P., et al. (2018). Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.Leukemia.

M

Gilleece, M.H., Labopin, M., Yakoub-Agha, I., Volin, L., Socié, G., Ljungman, P., Huynh, A., Deconinck, E., Wu, D., Bourhis, J.Henri, et al. (2018). Measurable residual disease, conditioning regimen intensity and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: a registry analysis of 2292 patients by the Acute Leukemia Working Party Eu.Am J Hematol.

Brands-Nijenhuis, A.V.M., Labopin, M., Schouten, H.C., Volin, L., Socié, G., Cornelissen, J.J., Huynh, A., Ljungman, P., Malard, F., Esteve, J., et al. (2015). Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission. A retrospective survey on behalf of the ALWP of EBMT.Haematologica.

R

Chevallier, P., Labopin, M., Socié, G., Tabrizi, R., Furst, S., Lioure, B., Guillaume, T., Delaunay, J., de la Tour, R.Peffault, Vigouroux, S., et al. (2014). Results from a clofarabine-busulfan containing reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase II prospective CLORIC trial.Haematologica.

S

Nagler, A., Labopin, M., Dholaria, B., Finke, J., Brecht, A., Schanz, U., Niittyvuopio, R., Neubauer, A., Bornhäuser, M., Santarone, S., et al. (2019). Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.Br J Haematol.

Belkacemi, Y., Labopin, M., Giebel, S., Gorin, N.Claude, Loganadane, G., Miszczyk, L., Michallet, M., Socié, G., Schaap, N.Pm, Cornelissen, J.J., et al. (2018). Single Dose Daily Fractionated Is Not Inferior To Twice A Day Fractionated Total Body Irradiation Prior To Allogeneic Stem Cell Transplantation For Acute Leukemia: A Useful Practice Simplification Resulting From The Sarasin Study.Int J Radiat Oncol Biol Phys.

Gorin, N.-C., Labopin, M., Blaise, D., de Groot, M., Socié, G., Bourhis, J.Henri, Ciceri, F., Polge, E., Nagler, A., and Mohty, M. (2019). Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood a.Cancer.

U

Ruggeri, A., Battipaglia, G., Labopin, M., Ehninger, G., Beelen, D., Tischer, J., Ganser, A., Schwerdtfeger, R., Glass, B., Finke, J., et al. (2016). Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study.J Hematol Oncol9, 89.